AI Company ‘Predictmedix’ Launches COVID-19 Screening Technology for Retailers

Get Safe Entry

Toronto-based artificial intelligence (AI) firm Predictmedix (CSE: PMED; OTCQB: PMEDF) has launched screening technologies that will assist businesses by detecting potential COVID-19 infection and other illnesses. The versatile technology will also be used to scan physical spaces to ensure that people are following protocol such as physical distancing and the mandated wearing of face masks.

Earlier this month, Predictmedix filed for a US patent for COVID-19 testing and the technology is being offered to businesses as the world shifts into a new normal. The ground-breaking technology has a wide range of uses and the publicly traded company is expected to see a rapid increase in its share price in the coming weeks amid increased awareness and retailer adoption.

Continue reading the article here.

Other News Articles